1. Home
  2. TECX vs INDI Comparison

TECX vs INDI Comparison

Compare TECX & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • INDI
  • Stock Information
  • Founded
  • TECX 2019
  • INDI 2007
  • Country
  • TECX United States
  • INDI United States
  • Employees
  • TECX N/A
  • INDI N/A
  • Industry
  • TECX
  • INDI Semiconductors
  • Sector
  • TECX
  • INDI Technology
  • Exchange
  • TECX Nasdaq
  • INDI Nasdaq
  • Market Cap
  • TECX 334.4M
  • INDI 471.6M
  • IPO Year
  • TECX 2018
  • INDI N/A
  • Fundamental
  • Price
  • TECX $21.51
  • INDI $2.65
  • Analyst Decision
  • TECX Buy
  • INDI Strong Buy
  • Analyst Count
  • TECX 6
  • INDI 6
  • Target Price
  • TECX $79.20
  • INDI $5.75
  • AVG Volume (30 Days)
  • TECX 172.8K
  • INDI 3.5M
  • Earning Date
  • TECX 05-08-2025
  • INDI 05-12-2025
  • Dividend Yield
  • TECX N/A
  • INDI N/A
  • EPS Growth
  • TECX N/A
  • INDI N/A
  • EPS
  • TECX N/A
  • INDI N/A
  • Revenue
  • TECX N/A
  • INDI $218,406,000.00
  • Revenue This Year
  • TECX N/A
  • INDI $8.47
  • Revenue Next Year
  • TECX N/A
  • INDI $38.02
  • P/E Ratio
  • TECX N/A
  • INDI N/A
  • Revenue Growth
  • TECX N/A
  • INDI N/A
  • 52 Week Low
  • TECX $13.70
  • INDI $1.53
  • 52 Week High
  • TECX $61.07
  • INDI $7.82
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • INDI 57.42
  • Support Level
  • TECX $21.20
  • INDI $2.29
  • Resistance Level
  • TECX $22.75
  • INDI $3.00
  • Average True Range (ATR)
  • TECX 1.43
  • INDI 0.20
  • MACD
  • TECX 0.01
  • INDI 0.02
  • Stochastic Oscillator
  • TECX 41.32
  • INDI 50.70

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

Share on Social Networks: